Philip G. Janicak, MD
- 6Articles
- 34.3KReads1
- 2008–2014Active
- 37Collaborators
- 245Citations2
About
Philip G. Janicak, MD, has published extensively on the use of transcranial magnetic stimulation (TMS) in the treatment of major depressive disorder (MDD), including studies on its safety, efficacy, and durability of benefit. His work also addresses adjunctive TMS use in depressed adolescents and evaluates the acute efficacy of aripiprazole across symptoms of schizophrenia and schizoaffective disorders. Janicak’s research spans clinical areas of depression, child and adolescent psychiatry, and schizophrenia, contributing to the understanding of novel therapeutic interventions.
Publications
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
